These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23939625)

  • 21. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cryotherapy and Radiofrequency Ablation for Eradication of Barrett's Esophagus with Dysplasia or Intramucosal Cancer.
    Thota PN; Arora Z; Dumot JA; Falk G; Benjamin T; Goldblum J; Jang S; Lopez R; Vargo JJ
    Dig Dis Sci; 2018 May; 63(5):1311-1319. PubMed ID: 29524114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia.
    Kim HP; Bulsiewicz WJ; Cotton CC; Dellon ES; Spacek MB; Chen X; Madanick RD; Pasricha S; Shaheen NJ
    Gastrointest Endosc; 2012 Oct; 76(4):733-9. PubMed ID: 22732872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.
    van Vilsteren FG; Alvarez Herrero L; Pouw RE; Schrijnders D; Sondermeijer CM; Bisschops R; Esteban JM; Meining A; Neuhaus H; Parra-Blanco A; Pech O; Ragunath K; Rembacken B; Schenk BE; Visser M; ten Kate FJ; Meijer SL; Reitsma JB; Weusten BL; Schoon EJ; Bergman JJ
    Endoscopy; 2013 Jul; 45(7):516-25. PubMed ID: 23580412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biopsy depth after radiofrequency ablation of dysplastic Barrett's esophagus.
    Shaheen NJ; Peery AF; Overholt BF; Lightdale CJ; Chak A; Wang KK; Hawes RH; Fleischer DE; Goldblum JR;
    Gastrointest Endosc; 2010 Sep; 72(3):490-496.e1. PubMed ID: 20598302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive factors of radiofrequency ablation failure in the treatment of dysplastic Barrett's esophagus.
    Weiss S; Pellat A; Corre F; Abou Ali E; Belle A; Terris B; Leconte M; Dohan A; Chaussade S; Coriat R; Barret M
    Clin Res Hepatol Gastroenterol; 2023 Jan; 47(1):102065. PubMed ID: 36494071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Outcomes Following Recurrence of Intestinal Metaplasia After Successful Treatment of Barrett's Esophagus With Radiofrequency Ablation.
    Guthikonda A; Cotton CC; Madanick RD; Spacek MB; Moist SE; Ferrell K; Dellon ES; Shaheen NJ
    Am J Gastroenterol; 2017 Jan; 112(1):87-94. PubMed ID: 27725648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection and staging of esophageal cancers within Barrett's esophagus is improved by assessment in specialized Barrett's units.
    Cameron GR; Jayasekera CS; Williams R; Macrae FA; Desmond PV; Taylor AC
    Gastrointest Endosc; 2014 Dec; 80(6):971-83.e1. PubMed ID: 24929493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic review comparing radiofrequency ablation and complete endoscopic resection in treating dysplastic Barrett's esophagus: a critical assessment of histologic outcomes and adverse events.
    Chadwick G; Groene O; Markar SR; Hoare J; Cromwell D; Hanna GB
    Gastrointest Endosc; 2014 May; 79(5):718-731.e3. PubMed ID: 24462170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stepwise radiofrequency ablation of Barrett's esophagus preserves esophageal inner diameter, compliance, and motility.
    Beaumont H; Gondrie JJ; McMahon BP; Pouw RE; Gregersen H; Bergman JJ; Boeckxstaens GE
    Endoscopy; 2009 Jan; 41(1):2-8. PubMed ID: 19160152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases.
    Schneider PM; Casson AG; Levin B; Garewal HS; Hoelscher AH; Becker K; Dittler HJ; Cleary KR; Troster M; Siewert JR; Roth JA
    J Thorac Cardiovasc Surg; 1996 Feb; 111(2):323-31; discussion 331-3. PubMed ID: 8583805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclooxygenase-2 expression in esophageal epithelium before and after photodynamic therapy for Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
    Yachimski P; Mino-Kenudson M; Sherwood ME; Puricelli WP; Nishioka NS; Lauwers GY
    Virchows Arch; 2011 Dec; 459(6):581-6. PubMed ID: 22081106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
    Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
    Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus.
    Weston AP; Krmpotich PT; Cherian R; Dixon A; Topalosvki M
    Am J Gastroenterol; 1997 Mar; 92(3):407-13. PubMed ID: 9068459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia.
    Pouw RE; Gondrie JJ; Rygiel AM; Sondermeijer CM; ten Kate FJ; Odze RD; Vieth M; Krishnadath KK; Bergman JJ
    Am J Gastroenterol; 2009 Jun; 104(6):1366-73. PubMed ID: 19491850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoscopic features of buried Barrett's mucosa.
    Yang LS; Holt BA; Williams R; Norris R; Tsoi E; Cameron G; Desmond P; Taylor ACF
    Gastrointest Endosc; 2021 Jul; 94(1):14-21. PubMed ID: 33373645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barrett's esophagus: the American perspective.
    Spechler SJ
    Dig Dis; 2013; 31(1):10-6. PubMed ID: 23797117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy?
    Rajendra S; Sharma P
    Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 31304554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of Barrett's esophagus with dysplasia refractory to radiofrequency ablation.
    Raphael KL; Trindade AJ
    World J Gastroenterol; 2020 May; 26(17):2030-2039. PubMed ID: 32536772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus.
    Cotton CC; Haidry R; Thrift AP; Lovat L; Shaheen NJ
    Gastroenterology; 2018 Aug; 155(2):316-326.e6. PubMed ID: 29655833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.